Are Options Traders Bullish on ATNX?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

About ATNX

Founded in 2003, Athenex, Inc. is a global clinical stage biopharmaceutical company dedicated to becoming a leader in the discovery and development of next generation drugs for the treatment of cancer. Athenex is organized around three platforms including an Oncology Innovation Platform, a Commercial Platform and a Global Supply Chain Platform. Athenexs Oncology Innovation Platform generates clinical candidates through an extensive understanding of kinases, including novel binding sites, human absorption biology and through the application of Athenexs proprietary research and selection processes in the lab. The Companys current clinical pipeline is derived from two different platform technologies Athenex calls Orascovery and Src Kinase Inhibition. The Orascovery platform is based on the novel oral P-glycoprotein pump inhibitor molecule HM30181A, through which Athenex is able to facilitate oral absorption of traditional cytotoxics, which Athenex believes may offer improved patient tolerability and efficacy as compared to IV administration of the same cytotoxics. The Src Kinase Inhibition platform refers to novel small molecule compounds that have multiple mechanisms of action, including the inhibition of the activity of Src Kinase and the inhibition of tubulin polymerization during cell division. Athenex believes the combination of these mechanisms of action provides a broader range of anti-cancer activity as compared to either mechanism of action alone.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ATNX is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 271.3 M 2.71337E+08 235 235 0.04% 0.000377187 224 K 224342
EQWS Invesco Russell 2000 Equal Weight ETF 19.8 M 1.98E+07 1,952 1952 0.03% 0.00025 5 K 4970
FHLC Fidelity MSCI Health Care Index ETF 1.5 B 1.5E+09 357 357 0.01% 0.00010081 149 K 148865
IBB iShares Nasdaq Biotechnology Index Fund 8.2 B 8.22135E+09 224 224 0.1% 0.001 8.4 M 8369430
IWM iShares Russell 2000 ETF 41.6 B 4.16227E+10 2,023 2023 0.03% 0.0003 10.6 M 1.05605E+07
IWO iShares Russell 2000 Growth ETF 8.7 B 8.73602E+09 1,249 1249 0.05% 0.0005 4.4 M 4372580
IWV iShares Russell 3000 ETF 9.5 B 9.48121E+09 2,990 2990 0.0% 0 168 K 167968
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.7 B 1.7E+09 1,016 1016 0.01% 9.31606E-05 159 K 158930
UBIO Proshares UltraPro Nasdaq Biotechnology 34.1 M 3.40656E+07 229 229 0.02% 0.000209342 24 K 23720
URTY ProShares UltraPro Russell2000 112.3 M 1.12258E+08 2,034 2034 0.0% 4.93134E-05 19 K 18639
UWM ProShares Ultra Russell2000 140.5 M 1.40506E+08 2,034 2034 0.01% 0.000114433 34 K 33596
XBI SPDR Series Trust SPDR S&P Biotech ETF 4.0 B 4.03039E+09 122 122 0.16% 0.00156452 6.3 M 6281954
FAD First Trust Multi Cap Growth AlphaDEX Fund 159.0 M 1.58956E+08 675 675 0.04% 0.0004 64 K 63582
FYC First Trust Small Cap Growth AlphaDEX Fund 278.4 M 2.78421E+08 262 262 0.22% 0.0022 613 K 612526
FYX First Trust Small Cap Core AlphaDEX Fund 561.0 M 5.61042E+08 525 525 0.05% 0.0005 281 K 280521

Wait, Before You Leave...